Thrombin Market

Thrombin Market (Product - Bovine Thrombin, Human Thrombin, and Recombinant Thrombin; Dosage Form - Powder Form and Solution Form; End User - Hospitals, Diagnostics Centers & Clinics, and Academics & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

  • Rep Id : TMRGL19580
  • Published On : Jan 2018
  • No. of Pages : 162
  • Category : Pharmaceutical

1. Preface
     1.1 Report Scope
     1.2 Market Segmentation 
     1.3 Research Highlights

2. Assumptions and Research Methodology
     2.1 Assumptions
     2.2 Acronyms Used
     2.3 Research Methodology

3. Executive Summary

4. Market Overview
     4.1 Product Overview
     4.2 Key Industry Developments
     4.3 Global Thrombin Market Size (US$ Mn) Forecast
     4.4 Market Opportunity Map
     4.5 Market Indicators
     4.6 Porter’s Analysis 
     4.7 Global Thrombin Market Outlook

5. Market Dynamics
     5.1 Drivers and Restraints Snapshot Analysis
     5.2 Drivers
     5.3 Restraints
     5.4 Opportunities
     5.5 Features of Ideal Hemostat at a glance
     5.6 Key Brand Analysis
     5.7 Regulatory Scenario 

6. Global Thrombin Market Analysis, by Product
     6.1 Key Findings
     6.2 Introduction
     6.3 Global Thrombin Market Value Share Analysis, by Product
     6.4 Global Thrombin Market Forecast, by Product
           6.4.1. Bovine Thrombin
           6.4.2. Human Thrombin
           6.4.3. Recombinant Thrombin
     6.5 Global Thrombin Market Analysis, by Product 
     6.6 Global Thrombin Market Attractiveness Analysis, by Product

7. Global Thrombin Market Analysis, by Dosage Form
     7.1 Key Findings
     7.2 Introduction
     7.3 Global Thrombin Market Value Share Analysis, by Dosage Form
     7.4 Global Thrombin Market Forecast, by Dosage Form
           7.4.1. Powder Forms
           7.4.2. Solution Forms
           7.4.3. Others
     7.5 Global Thrombin Market Analysis, by Dosage Form
     7.6 Global Thrombin Market Attractiveness Analysis, by Dosage Form

8. Global Thrombin Market Analysis, by End-user
     8.1 Key Findings
     8.2 Introduction
     8.3 Global Thrombin Market Value Share Analysis, by End-user
     8.4 Global Thrombin Market Forecast, by End-user
           8.4.1. Hospitals
           8.4.2. Diagnostics Centers & Clinics
           8.4.3. Academics and Research Institutes
     8.5 Global Thrombin Market Analysis, by End-user
     8.6 Global Thrombin Market Attractiveness Analysis, by End-user

9. Thrombin Market Analysis, by Region
     9.1 Global Thrombin Market Scenario
     9.2 Introduction
     9.3 Global Thrombin Market Value Share Analysis, by Region
           9.3.1 North America
           9.3.2 Europe
           9.3.3 Asia Pacific
           9.3.4 Rest of the World  
     9.4 Global Thrombin Market Forecast, by Region
     9.5 Global Thrombin Market Attractiveness Analysis, by Region

10. North America Thrombin Market Analysis
     10.1 Key Findings
     10.2 North America Thrombin Market Overview
     10.3 North America Thrombin Market Value Share Analysis, by Country
     10.4 North America Thrombin Market Forecast, by Country
           10.4.1. U.S.
           10.4.2. Canada
     10.5 North America Thrombin Market Value Share Analysis, by Product
     10.6 North America Thrombin Market Forecast, by Product
     10.7 North America Thrombin Market Value Share Analysis, by Dosage Form
     10.8 North America Thrombin Market Forecast, by Dosage Form
     10.9 North America Thrombin Market Value Share Analysis, by End-user
     10.10 North America Thrombin Market Forecast, by End-user
     10.11 North America Thrombin Market Attractiveness Analysis

11. Europe Thrombin Market Analysis
     11.1 Key Findings
     11.2 Europe Thrombin Market Overview
     11.3 Europe Thrombin Market Value Share Analysis, by Country
     11.4 Europe Thrombin Market Forecast, by Country
           11.4.1 Germany 
           11.4.2 U.K.
           11.4.3 France
           11.4.4 Italy
           11.4.5 Spain
           11.4.6 Rest of the Europe
     11.5 Europe Thrombin Market Value Share Analysis, by Product
     11.6 Europe Thrombin Market Forecast, by Product
     11.7 Europe Thrombin Market Value Share Analysis, by Dosage Form
     11.8 Europe Thrombin Market Forecast, by Dosage Form
     11.9 Europe Thrombin Market Value Share Analysis, by End-user
     11.10 Europe Thrombin Market Forecast, by End-user
     11.11 Europe Thrombin Market Attractiveness Analysis

12. Asia Pacific Thrombin Market Analysis
     12.1 Key Findings
     12.2 Asia Pacific Thrombin Market Overview
     12.3 Asia Pacific Thrombin Market Value Share Analysis, by Country
     12.4 Asia Pacific Thrombin Market Forecast, by Country
           12.4.1 Japan
           12.4.2 China 
           12.4.3 Australia & New Zealand
           12.4.4 Rest of Asia Pacific
     12.5 Asia Pacific Thrombin Market Value Share Analysis, by Product
     12.6 Asia Pacific Thrombin Market Forecast, by Product
     12.7 Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form
     12.8 Asia Pacific Thrombin Market Forecast, by Dosage Form
     12.9 Asia Pacific Thrombin Market Value Share Analysis, by End-user
     12.10 Asia Pacific Thrombin Market Forecast, by End-user
     12.11 Asia Pacific Thrombin Market Attractiveness Analysis

13. Rest of the World Thrombin Market Analysis
     13.1 Key Findings
     13.2 Rest of the World Thrombin Market Overview
     13.3 Rest of the World Thrombin Market Value Share Analysis, by Country
     13.5 Rest of the World Thrombin Market Value Share Analysis, by Product
     13.6 Rest of the World Thrombin Market Forecast, by Product
     13.7 Rest of the World Thrombin Market Value Share Analysis, by Dosage Form
     13.8 Rest of the World Thrombin Market Forecast, by Dosage Form
     13.9 Rest of the World Thrombin Market Value Share Analysis, by End-user
     13.10 Rest of the World Thrombin Market Forecast, by End-user
     13.11 Rest of the World Thrombin Market Attractiveness Analysis

14. Competition Landscape
     14.1 Competition Matrix 
     14.2 Thrombin Market: Heat Map Analysis by Company
     14.3 Company Profiles
           14.3.1 Johnson & Johnson Services, Inc.
                    14.3.1.1Company Details
                    14.3.1.1 Business Overview
                    14.3.1.2 Financial Overview
                    14.3.1.3 Strategic Overview
                    14.3.1.4 SWOT Analysis
           14.3.2 Pfizer, Inc.
                    14.3.2.1 Company Details
                    14.3.2.2 Business Overview
                    14.3.2.3 Financial Overview
                    14.3.2.4 Strategic Overview
                    14.3.2.5 SWOT Analysis
           14.3.3  Mallinckrodt Pharmaceuticals
                    14.3.3.1 Company Details
                    14.3.3.2 Business Overview
                    14.3.3.3 Financial Overview
                    14.3.3.4 Strategic Overview
                    14.3.3.5 SWOT Analysis
           14.3.4 Shanghai RAAS blood products co., Ltd.
                    14.3.4.1 Company Details
                    14.3.4.2 Business Overview
                    14.3.4.3 Financial Overview
                    14.3.4.4 Strategic Overview
                    14.3.4.5 SWOT Analysis
           14.3.5 Japan Blood Products Organization
                    14.3.5.1 Company Details
                    14.3.5.2 Business Overview
                    14.3.5.3 Strategic Overview
                    14.3.5.4 SWOT Analysis
           14.3.6 Mochida Pharmaceutical Co., Ltd. 
                    14.3.6.1 Company Details
                    14.3.6.2 Business Overview
                    14.3.6.3 Financial Overview
                    14.3.6.4 Strategic Overview
                    14.3.6.5 SWOT Analysis
           14.3.7 BIOFAC A/S
                    14.3.7.1 Company Details
                    14.3.7.2 Business Overview
                    14.3.7.3 Strategic Overview
                    14.3.7.4 SWOT Analysis
           14.3.8 Biomed-Lublin S.A.
                    14.3.8.1 Company Details
                    14.3.8.2 Business Overview
                    14.3.8.3 Financial Overview
                    14.3.8.4 Strategic Overview
                    14.3.8.5 SWOT Analysis
           14.3.9 Hualan Biological Engineering, Inc.
                    14.3.9.1 Company Details
                    14.3.9.2 Business Overview
                    14.3.9.3 Strategic Overview
                    14.3.9.4 SWOT Analysis

List of Tables

Table 01: Global Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 03: Global Thrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Thrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 06: North America Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 07: North America Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 08: Europe Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: Europe Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 10: Europe Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 11: Europe Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 12: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 14: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 15: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 17: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 18: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 19: Johnson & Johnson Services, Inc.  Products & Services Offered
Table 20: Pfizer, Inc.  Business Overview
Table 21: Mallinckrodt Pharmaceuticals Business Overview
Table 22: Shanghai RAAS blood products co., Ltd. Business Overview
Table 23: Japan Blood Products Organization Business Overview
Table 24: Mochida Pharmaceutical Co., Ltd. Business Overview
Table 25: BIOFAC A/S Business Overview
Table 26: Biomed-Lublin S.A. Business Overview
Table 27: Hualan Biological Engineering, Inc. Business Overview

List of Figures

Figure 01: Global Thrombin Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Region (2016)
Figure 03: Market Value Share, by Product (2016)
Figure 04: Market Value Share, by Dosage Form (2016)
Figure 05: Market Value Share, by End User (2016)
Figure 06: Global Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 07: Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bovine Thrombin, 2015–2025
Figure 08: Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Human Thrombin, 2015–2025
Figure 09: Global Thrombin Market Revenue (US$ Mn) and
Figure 10: Global Thrombin Market Attractiveness Analysis, by Product, 2017–2025
Figure 11: Global Thrombin Market Value Share, by Dosage Form, 2016 and 2025
Figure 12: Global Thrombin Market Revenue (US$ Mn), by Powder Form, 2015–2025
Figure 13: Global Thrombin Market Revenue (US$ Mn), by Solution Form, 2015–2025
Figure 14: Global Thrombin Market Revenue (US$ Mn), by Others, 2015–2025
Figure 15: Global Thrombin Market Attractiveness, by Dosage Form, 2015–2025
Figure 16: Global Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 17: Global Thrombin Market Revenue (US$ Mn), by Human Source, 2015–2025
Figure 18: Global Thrombin Market Revenue (US$ Mn), by Diagnostic Centers & Clinics Source, 2015–2025
Figure 19: Global Thrombin Market Revenue (US$ Mn), by Academic and Research Institutes, 2015–2025
Figure 20: Global Thrombin Market Attractiveness Analysis, by End-user, 2015–2025
Figure 21: Global Thrombin Market Value Share Analysis, by Region, 2016 and 2025
Figure 22: Global Thrombin Market Attractiveness Analysis, by Region, 2015–2025 
Figure 23: North America Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 24: North America Thrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 25: North America Thrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 26: North America Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 27: North America Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 28: North America Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 29: North America Thrombin Market Attractiveness Analysis, by Product,
Figure 30: North America Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 31: North America Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 32: Europe Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 33: Europe Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 34: Europe Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 35: Europe Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 36: Europe Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 37: Europe Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 38: Europe Thrombin Market Attractiveness Analysis, by Product,
Figure 39: Europe Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 40: Europe Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 41: Asia Pacific Thrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 42: Asia Pacific Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 43: Asia Pacific Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 44: Asia Pacific Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 45: Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 46: Asia Pacific Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 47: Asia Pacific Thrombin Market Attractiveness Analysis, by Product,
Figure 48: Asia Pacific Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 49: Asia Pacific Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 50: Rest of the World Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Rest of the World Thrombin Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Rest of the World Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 53: Rest of the World Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
Figure 54: Rest of the World Thrombin Market Attractiveness Analysis, by Product,
Figure 55: Rest of the World Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 56: Rest of the World Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
Figure 57: Thrombin Market: Heat Map Analysis by Company
Figure 58: Johnson & Johnson Services, Inc. Breakdown of Net Sales (US$ Mn)
Figure 59: Johnson & Johnson Services, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
Figure 60: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Region, 2017
Figure 61: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 62: Pfizer Inc. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 63: Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
Figure 64: Pfizer, Inc. Breakdown of Net Sales (2016), by Region
Figure 65: Pfizer, Inc. Number of Discovery Projects till February 2016
Figure 66: Mallinckrodt Pharmaceuticals Breakdown of Net Sales, by Business Segment, 2016
Figure 67: Mallinckrodt Pharmaceuticals Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Shanghai RAAS blood products co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2015
Figure 69: Mochida Pharmaceutical Co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 70: Biomed-Lublin S.A. revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 71: Global Thrombin Market Revenue Split, By Product (2016)
Figure 72: Global Thrombin Market Revenue Split, By Dosage Form (2016)
Figure 73: Global Thrombin Market Revenue Split, By Region (2016)

.